BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9308122)

  • 41. [Management of ascitis in patients with cirrhosis].
    Arfaoui D; Ajmi S
    Tunis Med; 2007 Feb; 85(2):91-5. PubMed ID: 17665651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transjugular intrahepatic portosystemic stent-shunt after orthotopic liver transplantation in a patient with early recurrence of portal hypertension of unknown origin.
    Nolte W; Canelo R; Figulla HR; Kersten J; Sattler B; Münke H; Hartmann H; Ringe B; Ramadori G
    Z Gastroenterol; 1998 Feb; 36(2):159-64. PubMed ID: 9544499
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Surgical approach to posthepatitic cirrhotic patient today].
    Meriggi F; Forni E
    G Chir; 1996; 17(6-7):370-8. PubMed ID: 9272983
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renaissance of paracentesis in the treatment of ascites.
    Reynolds TB
    Adv Intern Med; 1990; 35():365-73. PubMed ID: 2405598
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of cirrhotic ascites.
    Alaniz C
    Clin Pharm; 1989 Sep; 8(9):645-54. PubMed ID: 2676316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation between increased colloid osmotic pressure and the resolution of refractory ascites after transjugular intrahepatic portosystemic shunt.
    Schiano TD; Black M; Hills C; Ter H; Bellary S; Miller LS
    South Med J; 2000 Mar; 93(3):305-9. PubMed ID: 10728519
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surgical treatment of portal hypertension.
    Wang Y
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):211-4. PubMed ID: 14607741
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of ascites in patients with cirrhosis of the liver.
    Arroyo V; Ginés P; Rodés J
    J Hepatol; 1986; 2(3):504-12. PubMed ID: 3522726
    [No Abstract]   [Full Text] [Related]  

  • 49. Palliative treatment of malignant ascites #177.
    LeBlanc K; Arnold RM
    J Palliat Med; 2010 Aug; 13(8):1028-9. PubMed ID: 20712467
    [No Abstract]   [Full Text] [Related]  

  • 50. Management of ascites.
    Dudley FJ; Watanabe A
    J Gastroenterol Hepatol; 1992; 7(4):439-46. PubMed ID: 1515572
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of ascites between the end of the 19th century and the beginning of the 20th century: Brief historical summary.
    Cozza A; Maggioni G; Rippa Bonati M; Zampetti P; Amodio P
    Dig Liver Dis; 2021 Nov; 53(11):1522-1523. PubMed ID: 34266793
    [No Abstract]   [Full Text] [Related]  

  • 52. [Cirrhosis in African children in Dakar].
    Sanokho A; Kuakuvi N; Kessie F; Zohoun I; Bayo PN; N'Diaye PO
    Bull Soc Med Afr Noire Lang Fr; 1975; 20(1):20-5. PubMed ID: 1230314
    [No Abstract]   [Full Text] [Related]  

  • 53. [Liver cirrhosis. 1953].
    Hetényi G
    Orv Hetil; 2003 Jan; 144(4):187-97. PubMed ID: 12621817
    [No Abstract]   [Full Text] [Related]  

  • 54. Art, medicine and surgery: puncture of ascites.
    Van Hee R; Dequeker J; Vanopdenbosch L
    Acta Chir Belg; 2010; 110(4):492-7. PubMed ID: 20919677
    [No Abstract]   [Full Text] [Related]  

  • 55. [The "productions cirrhoses" of R. Th. H. Laennec].
    Boitout H
    Med Welt; 1965 Jul; 27():1537-40. PubMed ID: 5320173
    [No Abstract]   [Full Text] [Related]  

  • 56. Ascites as described by Aulus Cornelius Celsus (ca. A. D. 30).
    JARCHO S
    Am J Cardiol; 1958 Oct; 2(4):507-8. PubMed ID: 13582896
    [No Abstract]   [Full Text] [Related]  

  • 57. Laennec.
    HEAD JR
    Q Bull Northwest Univ Med Sch; 1960; 34(3):266-72. PubMed ID: 14400401
    [No Abstract]   [Full Text] [Related]  

  • 58. Effectiveness of tolvaptan monotherapy and low-dose furosemide/tolvaptan combination therapy for hepatoprotection and diuresis in a rat cirrhotic model.
    Tanabe N; Takami T; Fujisawa K; Matsumoto T; Yamamoto N; Sakaida I
    J Clin Biochem Nutr; 2017 Jul; 61(1):53-59. PubMed ID: 28751810
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictors of the Effect of Tolvaptan on the Prognosis of Cirrhosis.
    Iwamoto T; Maeda M; Hisanaga T; Saeki I; Fujisawa K; Matsumoto T; Hidaka I; Ishikawa T; Takami T; Sakaida I
    Intern Med; 2016; 55(20):2911-2916. PubMed ID: 27746425
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alcoholic liver disease - the extent of the problem and what you can do about it.
    Hazeldine S; Hydes T; Sheron N
    Clin Med (Lond); 2015 Apr; 15(2):179-85. PubMed ID: 25824072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.